Join two international experts as they discuss practical approaches in two areas of growing importance: Plasma treatment in ABO-incompatible transplantation and Red cell depletion with Therapeutic erythrocytapheresis (TEA).
Join two international experts as they discuss innovative approaches to apheresis, focusing on the role of new drugs and plasma exchange in managing neuroimmune disorders and the customization of apheresis collections to support hematopoietic stem cell gene therapies.
CAR T-cell therapy (Chimeric Antigen Receptor) is a new type of cancer immunotherapy that uses genetically engineered T cells with synthetic antigen-specific receptors. This is a revolutionary new approach in cancer treatment.